Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
Pharmaceuticals in Russia
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Russian pharmaceuticals market had total revenues of $24.5m in 2018, representing ... and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts REASONS TO BUY What ...
November 2025
39 pages
Pharmaceuticals in Brazil
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Brazilian pharmaceuticals market had total revenues of $23.6m in 2018, ... and pitches by understanding the future growth prospects of the Brazil pharmaceuticals market with five year forecasts REASONS TO BUY What ...
November 2025
38 pages
Pharmaceuticals in Mexico
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Mexican pharmaceuticals market had total revenues of $20.7m in 2018, representing ... and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts REASONS TO BUY What ...
November 2025
45 pages
Pharmaceuticals in Singapore
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Singaporean pharmaceuticals market had total revenues of $1.0m in 2018, ... was the size of the Singapore pharmaceuticals market by value in 2018? What will be the size of the Singapore pharmaceuticals market in 2023? What ...
November 2025
46 pages
Pharmaceuticals in Europe
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The European pharmaceuticals market had total revenues of $286.9m in 2018, ... and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts REASONS TO BUY What was ...
November 2025
51 pages
Global Pharmaceuticals
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The global pharmaceuticals market had total revenues of $1,111.8m in 2018, ... and pitches by understanding the future growth prospects of the Global pharmaceuticals market with five year forecasts REASONS TO BUY What was ...
November 2025
47 pages
Pharmaceuticals in Spain
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Spanish pharmaceuticals market had total revenues of $25.5m in 2018, representing ... and pitches by understanding the future growth prospects of the Spain pharmaceuticals market with five year forecasts REASONS TO BUY What ...
November 2025
36 pages
Pharmaceuticals in Italy
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Italian pharmaceuticals market had total revenues of $28.5m in 2018, representing ... and pitches by understanding the future growth prospects of the Italy pharmaceuticals market with five year forecasts REASONS TO BUY What ...
November 2025
44 pages
Pharmaceuticals in Germany
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The German pharmaceuticals market had total revenues of $78.0m in 2018, representing ... and pitches by understanding the future growth prospects of the Germany pharmaceuticals market with five year forecasts REASONS TO BUY What ...
November 2025
46 pages
Pharmaceuticals in France
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The French pharmaceuticals market had total revenues of $37.4m in 2018, representing ... and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts REASONS TO BUY What ...
November 2025
46 pages
Pharmaceuticals in China
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Chinese pharmaceuticals market had total revenues of $132.9m in 2018, ... and pitches by understanding the future growth prospects of the China pharmaceuticals market with five year forecasts REASONS TO BUY What was ...
November 2025
43 pages
Pharmaceuticals in Canada
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Canadian pharmaceuticals market had total revenues of $23.5m in 2018, representing ... and pitches by understanding the future growth prospects of the Canada pharmaceuticals market with five year forecasts REASONS TO BUY What ...
November 2025
43 pages
Pharmaceuticals in Japan
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Japanese pharmaceuticals market had total revenues of $70.9m in 2018, representing ... and pitches by understanding the future growth prospects of the Japan pharmaceuticals market with five year forecasts REASONS TO BUY What ...
November 2025
47 pages
Pharmaceuticals in Asia-Pacific
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Asia-Pacific pharmaceuticals market had total revenues of $324.8m in 2018, representing a compound ...
November 2025
44 pages
Pharmaceuticals in South Africa
US$ 350.00
... healthcare system. SCOPE Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Africa ...
November 2025
46 pages
Pharmaceuticals in Indonesia
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Indonesian pharmaceuticals market had total revenues of $7.1m in 2018, ... was the size of the Indonesia pharmaceuticals market by value in 2018? What will be the size of the Indonesia pharmaceuticals market in 2023? What ...
November 2025
41 pages
Pharmaceuticals in North America
US$ 350.00
... consumer healthcare or animal healthcare. The North American pharmaceuticals market had ... North America pharmaceuticals market by value in 2018? What will be the size of the North America pharmaceuticals market in 2023? What factors are affecting the strength of competition in the North America pharmaceuticals ...
November 2025
44 pages
Pharmaceuticals in Scandinavia
US$ 350.00
... ethical drugs only and does not include consumer healthcare or animal healthcare. The Scandinavian pharmaceuticals market had total revenues of $13.1m in 2018, ... was the size of the Scandinavia pharmaceuticals market by value in 2018? What will be the size of the Scandinavia pharmaceuticals market in 2023? What ...
November 2025
40 pages
Pharmaceuticals in Turkey
US$ 350.00
... of ethical drugs only and does not include consumer healthcare or animal healthcare. The Turkish pharmaceuticals market had total revenues of $6.0m in 2018, representing ... and pitches by understanding the future growth prospects of the Turkey pharmaceuticals market with five year forecasts REASONS TO BUY What ...
November 2025
39 pages
Pharmaceuticals in the Netherlands
US$ 350.00
Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The pr...
November 2025
42 pages
Pharmaceuticals in the United Kingdom
US$ 350.00
Pharmaceuticals in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile al...
November 2025
41 pages
Pharmaceuticals in the United States
US$ 350.00
Pharmaceuticals in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast...
November 2025
47 pages
Non-alcoholic Steatohepatitis Treatment Market - 2025-2031
US$ 3,400.00
Non-alcoholic Steatohepatitis Treatment Marketis is growing with a CAGR of 54.00% during the forecast period 2026-2035. The Non-alcoholic Steatohepatitis Treatment Market emerges as a key focus in Dat...
November 2025
65 pages
Animal Anti-rabies Vaccine Market - 2026-2031
US$ 3,400.00
Animal Anti-rabies Vaccine Market reached US$ 464.14 million in 2023 and is expected to reach US$ 646.98 million by 2031, growing with a CAGR of 4.20% during the forecast period 2026-2031. The Animal...
November 2025
52 pages
Global Oral Diuretic Drugs Market Growth 2025-2031
US$ 3,660.00
The global Oral Diuretic Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The global pharmaceutical marke...
November 2025
119 pages
U.S. Pharmacy Market Size, Share & Trends Analysis Report By Product Type (Prescription, OTC), By Type (Hospital Pharmacy, Retail Chains, ePharmacy), By Ownership, And Segment Forecasts, 2025 - 2033
US$ 3,950.00
The U.S. pharmacy market size was estimated at USD 732.44 billion in 2024 and is projected to reach at USD 1,707.02 billion by 2033, growing at a CAGR of 9.91% from 2025 to 2033. The growth is attribu...
November 2025
100 pages
Intersectional Neurodiversity Market Forecasts to 2032 – Global Analysis By Neurodivergent Condition (Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), Dyslexia and Learning Disabilities, Tourette Syndrome, Sensory Processing Disorder and Other Conditions), Component, Deployment Mode, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Intersectional Neurodiversity Market is accounted for $135.3 million in 2025 and is expected to reach $314.5 million by 2032 growing at a CAGR of 12.8% during...
November 2025
200 pages
Non-Pharmacologic Modulators Market Forecasts to 2032 – Global Analysis By Modality (Cognitive Behavioral Therapy (CBT), Mindfulness-Based Stress Reduction (MBSR), Biofeedback, Neurofeedback, Transcranial Magnetic Stimulation (TMS) and Other Modalities), Mechanism of Action, Delivery Mode, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Non-Pharmacologic Modulators Market is accounted for $1.78 billion in 2025 and is expected to reach $2.55 billion by 2032 growing at a CAGR of 5.2% during the...
November 2025
200 pages
Pharma Hub And Patient Access Support Service Market Size, Share & Trends Analysis Report By Service Type (Program Enrollment, Treatment Navigators, Reimbursement Services/Affordability Services, Clinical Educator), By Service Delivery Type, By Region, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The global pharma hub and patient access support service market size was estimated at USD 3.24 billion in 2024 and is projected to reach USD 7.63 billion by 2033, growing at a CAGR of 10.0% from 2025...
November 2025
100 pages
